Stimulant-free daily capsule formula combines Green Coffee Bean, L-Tyrosine, Theobromine, Bacopa Monnieri, Rhodiola Root, Huperzia Serrata, Rice Flour and Magnesium Stearate to support brain function, with a plain-language summary of published research on each ingredient
AURORA, Colo., Sept. 25, 2026 — CogniCare Pro today announced the availability of its cognitive support supplement, a daily capsule formula combining eight ingredients selected for their published research relevance to brain function, attention, working memory, and stress-related fatigue. The product contains no pharmaceutical stimulants and is manufactured in a GMP-compliant facility in the United States.
Alongside its launch, CogniCare Pro is publishing an overview of the published research on each ingredient in its formula — including both what studies have found and where evidence remains preliminary, limited to specific populations, or restricted to laboratory models.
“When I started working on this formula, I wanted every ingredient to have a reason to be there that I could point to in the published literature,” said Elizabeth Bennett, Creator of CogniCare Pro. “That means being honest about where the research is strong, where it is encouraging but early, and where an ingredient serves a formulation role rather than a standalone nootropic purpose.”
A Stimulant-Free Cognitive Support Formula
CogniCare Pro is taken as one capsule daily before a meal. Because it is an ingestible dietary supplement, it is subject to the FDA’s regulatory framework under DSHEA. Like all dietary supplements, it has not undergone the pre-market approval process required of pharmaceutical drugs, and its specific formula has not been evaluated in published randomized controlled trials.
The formula combines ingredients across two categories: botanicals and amino acid derivatives with published cognitive research (Bacopa Monnieri, Rhodiola Root, Huperzia Serrata, L-Tyrosine, Green Coffee Bean, Theobromine); and formulation excipients that support capsule manufacturing (Rice Flour, Magnesium Stearate). The product is non-habit forming and contains no added stimulants beyond naturally occurring compounds in its botanical ingredients.
Bacopa Monnieri: The Most Clinically Studied Ingredient in the Formula
Bacopa Monnieri (Bacopa monnieri) is the ingredient in the CogniCare Pro formula with the largest body of controlled human clinical research relevant to cognitive function. A 2024 randomized, double-blind, placebo-controlled trial published in the Journal of Psychiatry and Cognitive Behavior (B-Lit Bacopa, 300 mg daily for 12 weeks, 80 healthy adults) found significant improvements in short-term memory, spatial working memory, episodic memory, and cognitive performance compared to placebo, alongside improvements in mood and anxiety scores [1]. An earlier 90-day double-blind, placebo-controlled trial (KeenMind extract, 300 mg daily) found significant improvements in spatial working memory accuracy and reduced false-positive rates on a rapid visual information processing task [2].
Six systematic reviews or meta-analyses of Bacopa trials have been published. The Alzheimer’s Drug Discovery Foundation’s 2024 Cognitive Vitality Report on Bacopa Monnieri — prepared by neuroscientists — concludes that preclinical and early clinical data suggest cognitive benefit, but notes that larger, longer studies are needed to confirm it [3]. CogniCare Pro does not represent Bacopa Monnieri as a proven treatment for cognitive decline or any neurological condition.
Rhodiola Root: Stress-Related Fatigue With Replicated Clinical Evidence
Rhodiola Root (Rhodiola rosea) is an adaptogenic botanical with one of the more replicated evidence bases among natural cognitive support ingredients. A randomized, double-blind, placebo-controlled, parallel-group study published in Planta Medica (Olsson et al., 2009) found that 576 mg/day of standardized SHR-5 Rhodiola rosea extract significantly reduced fatigue, improved concentration, and reduced cortisol response to stress compared to placebo in 60 participants with stress-related fatigue syndrome [4]. A separate double-blind crossover study published in Phytomedicine (Darbinyan et al., 2000) involving 56 healthy physicians found significant improvement in a composite Fatigue Index measuring mental performance during night duty [5].
A 2022 review in Molecules summarized multiple clinical trials documenting improvements in stress symptoms, fatigue, mood, and quality of life. An 11-trial systematic review found promising results for mental fatigue in three of five relevant trials. The mechanism is attributed to Rhodiola’s active compounds — rosavins and salidrosides — which modulate the hypothalamic-pituitary-adrenal (HPA) axis and influence neurotransmitter levels including serotonin, dopamine, and norepinephrine. CogniCare Pro includes Rhodiola Root primarily for its evidence base in stress-related fatigue and mental performance under pressure, not as a treatment for clinical depression or anxiety disorders.
Huperzia Serrata (Huperzine A): Acetylcholinesterase Inhibition With Human Trial Evidence
Huperzia Serrata is the botanical source of Huperzine A, a naturally occurring alkaloid and reversible inhibitor of acetylcholinesterase — the enzyme responsible for breaking down acetylcholine in the synaptic cleft. By inhibiting this enzyme, Huperzine A increases the availability of acetylcholine, a neurotransmitter central to learning, memory, and attention.
A phase II randomized, double-blind, placebo-controlled multicenter study of Huperzine A (200–400 µg twice daily) in 210 patients with mild-to-moderate Alzheimer’s disease found improvements in cognitive assessment scores compared to placebo [6]. A meta-analysis published in PLOS ONE (Yang et al., 2013) evaluated Huperzine A across multiple randomized trials and found evidence of cognitive benefit, though the authors noted methodological limitations in the included studies [7].
Important caveats apply. The majority of controlled Huperzine A trials have been conducted in populations with existing cognitive impairment or Alzheimer’s disease — not in healthy adults seeking general cognitive support. The evidence for cognitive enhancement in healthy individuals is less well established. Individuals taking anticholinesterase medications, cardiac medications, or those with a history of seizures should consult a physician before use.
L-Tyrosine: Cognitive Performance Under Stress — Strongest in Acute Depletion Conditions
L-Tyrosine is a non-essential amino acid and direct precursor to the catecholamine neurotransmitters dopamine, norepinephrine, and epinephrine. It has been studied primarily for its effects on cognitive performance under conditions of acute stress, fatigue, or catecholamine depletion.
Published research shows L-Tyrosine is most effective when cognitive demands are high and catecholamine levels are naturally depleted — for example, during sleep deprivation, extreme cold, or high cognitive load. A review in Neuroscience and Biobehavioral Reviews (Jongkees et al., 2015) found that tyrosine supplementation consistently benefits cognitive performance in demanding conditions, particularly for working memory and task-switching [8]. Effects in well-rested adults under normal conditions are less consistently demonstrated. CogniCare Pro includes L-Tyrosine as a cognitive support ingredient with the strongest evidence in high-demand or high-stress scenarios.
Green Coffee Bean: Mental Alertness Via Chlorogenic Acids and Caffeine
Green Coffee Bean extract contains two relevant active compounds: chlorogenic acids (antioxidants) and caffeine. The caffeine content — present at lower levels than in roasted coffee — contributes to alertness and mental response time, consistent with caffeine’s well-established cognitive effects. The chlorogenic acid content contributes an antioxidant dimension.
CogniCare Pro’s website notes that green coffee bean supports mental response time, consistent with caffeine’s documented effects on reaction time and sustained attention in published research. Consumers sensitive to caffeine should be aware that Green Coffee Bean extract contains naturally occurring caffeine, even though the formula does not add stimulants independently.
Theobromine: Xanthine Alkaloid With Attention and Alertness Research
Theobromine is a methylxanthine alkaloid naturally occurring in cacao (Theobroma cacao) and structurally related to caffeine. It produces milder, longer-lasting stimulatory effects than caffeine due to slower metabolism. Published research on theobromine’s cognitive and mood effects in humans is limited and produces mixed findings. The most rigorous human study — a within-subjects placebo-controlled trial published in Psychopharmacology (Berl) (Baggott et al., 2013, University of Chicago, n=80) — tested oral theobromine at 250, 500, and 1,000 mg against a caffeine control. Caffeine produced expected effects on alertness; theobromine showed limited subjective effects at 250 mg and negative mood effects at higher doses, with dose-dependent increases in heart rate [9]. The study authors concluded that theobromine at normal dietary intake ranges may contribute modestly to the positive effects of chocolate, but that effects become negative at higher intakes. CogniCare Pro includes theobromine as a naturally occurring cacao-derived compound; its independent contribution to cognitive support at the dose in this formula has not been established in controlled trials.
Rice Flour and Magnesium Stearate: Formulation Excipients
Rice flour and magnesium stearate are standard pharmaceutical and supplement manufacturing excipients. Rice flour serves as a capsule filler and flow agent. Magnesium stearate is a widely used lubricant that prevents ingredients from sticking to manufacturing equipment during encapsulation, ensuring consistent dose delivery. Neither ingredient contributes a pharmacological cognitive effect; both are included for manufacturing and formulation consistency. CogniCare Pro does not attribute cognitive outcomes to these two ingredients.
What Ingredient Research Does and Does Not Show
CogniCare Pro’s research overview separates three questions: what each ingredient is, what researchers have independently found about it, and what has been demonstrated for the finished formula taken as a daily capsule.
The studies referenced examined individual ingredients, often at specific doses, in particular populations, under controlled conditions that may differ from daily supplementation in healthy adults. The finished formula combines eight ingredients in a single daily capsule, and its specific combination has not been evaluated in published randomized controlled trials. CogniCare Pro does not describe its product as clinically proven or attribute individual ingredient findings to the complete formula.
“Bacopa and Rhodiola have the strongest independent evidence bases in this formula — both have multiple controlled human trials,” Bennett added. “Huperzine A has compelling mechanistic research and human trials, primarily in older or cognitively impaired populations. L-Tyrosine has solid evidence specifically under high-stress conditions. The two excipients are there for manufacturing quality, not cognitive effect. We think people deserve to know the distinction.”
Safety and Suitability
CogniCare Pro is an ingestible dietary supplement. Users should be aware of the following:
- Individuals who are pregnant, nursing, taking prescription medications, or have a diagnosed medical condition should consult a physician before use.
- Huperzine A interacts with anticholinesterase medications. Anyone taking medications for Alzheimer’s disease, myasthenia gravis, or related conditions should not take this product without physician guidance.
- Green Coffee Bean extract contains naturally occurring caffeine. Individuals sensitive to caffeine should monitor their response.
- Rhodiola Root has mild stimulating properties; it is generally recommended to take it in the morning to avoid sleep disruption.
- This product is not intended to diagnose, treat, cure, or prevent any neurological condition, including Alzheimer’s disease, dementia, or cognitive decline.
- The formula contains no known habit-forming compounds and no pharmaceutical stimulants as added ingredients.
Product Format and Availability
CogniCare Pro is available to U.S. consumers through its official website at getcognipro.com. The product is supplied as capsules, with a recommended dose of one capsule daily before a meal. It is available in 60-day, 90-day, and 180-day supply packages with a 90-day money-back guarantee.
About CogniCare Pro
CogniCare Pro is a daily cognitive support supplement combining botanical extracts, amino acid derivatives, and formulation excipients in a stimulant-free capsule format, manufactured in a GMP-compliant U.S. facility.
CogniCare Pro’s mission is to give consumers a transparent, research-informed overview of what cognitive support ingredients are, what the published science supports, and where the evidence remains preliminary — so individuals can make genuinely informed choices about brain health supplementation.
References
[1] B-Lit Bacopa (Bacopa monnieri extract, 300 mg/day, 90 mg bacosides) randomized, double-blind, placebo-controlled trial in 80 healthy adults aged 18–55. Journal of Psychiatry and Cognitive Behavior. 2024;9(1). doi:10.4172/2471-2701. Sponsored by Samriddh ingredient supplier; independent replication not yet published.
[2] Stough C, Lloyd J, Clarke J, et al. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology (Berl). 2001;156(4):481–484. doi:10.1007/s002130100815. PMID: 11498727.
[3] Alzheimer’s Drug Discovery Foundation. Cognitive Vitality Report: Bacopa monnieri. Updated October 2024. Available at: alzdiscovery.org.
[4] Olsson EMG, von Schéele B, Panossian AG. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Medica. 2009;75(2):105–112. doi:10.1055/s-0028-1088346.
[5] Darbinyan V, et al. Rhodiola rosea in stress induced fatigue — a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine. 2000;7(5):365–371. doi:10.1016/S0944-7113(00)80055-0.
[6] Rafii MS, et al. A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology. 2011;76(16):1389–1394.
[7] Yang G, et al. Huperzine A for Alzheimer’s disease: a systematic review and meta-analysis of randomized clinical trials. PLOS ONE. 2013;8(9):e74916. doi:10.1371/journal.pone.0074916.
[8] Jongkees BJ, et al. Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands — a review. Journal of Psychiatric Research. 2015;70:50–57. doi:10.1016/j.jpsychires.2015.08.014.
[9] Baggott MJ, Childs E, Hart AB, de Bruin E, Palmer AA, Wilkinson JE, de Wit H. Psychopharmacology of theobromine in healthy volunteers. Psychopharmacology (Berl). 2013;228(1):109–118. doi:10.1007/s00213-013-3021-0. PMID: 23420115. Note: theobromine showed limited effects at 250 mg and negative mood effects at higher doses; caffeine outperformed theobromine on alertness measures.
Media Contact
Elizabeth Bennett, Creator CogniCare Pro
19655 E 35th Dr #100, Aurora, CO 80011, USA
Email: support@cognicarepro.com
Phone: 1-800-390-6035
Website: getcognipro.com
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Research referenced in this release concerns individual ingredients studied independently and does not constitute clinical evaluation of the complete CogniCare Pro formula or endorsement by the cited researchers, journals or institutions.
The post CogniCare Pro Reviews: Launches Cognitive Support a With Ingredient-by-Ingredient Research Overview appeared first on 24 Health Times.
